Nattokinase is an enzyme present in nattō, a traditional Japanese food. It has strong blood clot-dissolving activity, and it reduces blood pressure and high cholesterol, which highlights its potential for use in the treatment of heart disease. Read on to learn more about the health benefits of nattokinase.
What is Nattokinase?
Nattokinase, also known as natto extract (subtilisin NAT or orokinase) is an enzyme in nattō, a fermented soybean product. It is produced when the soybeans are cooked and later fermented by adding the bacteria, Bacillus subtilis natto [R].
It was discovered and extracted from nattō in 1987 when nattō was found to dissolve artificial fibrin (an insoluble protein involved in the formation of a blood clot). It has the highest anti-clotting (fibrinolytic) activity compared to other enzymes, making it a promising potential treatment for heart disease [R].
Another advantage is that it can be either be consumed as a dietary supplement or orally administered [R].
Nattokinase has been extensively studied in Japan, Korea, and China. However, only recently has this enzyme been recognized for its powerful clot-dissolving properties in Western medicine [R].
Mechanisms of Action
Despite its name, nattokinase is not a kinase enzyme but instead belongs to the serine protease family of enzymes, which work to break down other proteins. The mechanisms of action studied in animals or human cells, are as follows. Nattokinase [R, R, R]:
- Directly dissolves cross-linked fibrin
- Increases release of tissue plasminogen activator (t-PA) from cells, which also breaks down fibrin
- Increases urokinase levels by converting internal prourokinase to urokinase. More of this enzyme will lead to more plasmin in the blood, which is responsible for degrading fibrin
- Inactivates plasminogen activator inhibitor-1 (PAI-1). PAI-1 inhibits plasmin formation, which, as mentioned above, degrades fibrin
- Inhibits platelet aggregation by blocking thromboxane (a substance released from platelets that causes blood clotting and blood vessel constriction) formation
Health Benefits of Nattokinase
1) Nattokinase May Decrease Blood Pressure
Nattokinase inhibits the angiotensin-converting enzyme, which causes narrowing of blood vessels. Inhibiting this enzyme may be involved in reducing blood pressure [R].
In 2 clinical trials (DB-RCT), one with 79 and the other with 86 subjects with high blood pressure, the group which received a dose of nattokinase once a day for 8 weeks had reduced blood pressure (systolic and diastolic) compared to the placebo group. One of the studies found the reduction in blood pressure was more significant in male subjects [R, R].
2) Nattokinase May Prevent Blood Clots
Nattokinase has the potential to be a treatment for thrombosis (formation of a blood clot inside a blood vessel).
In a clinical trial (open-label, self-controlled design), 45 subjects were divided into 3 groups and received nattokinase daily for 2 months: a healthy group, patients at the risk of heart disease, and patients undergoing dialysis. Risk factors for heart disease (fibrinogen, factor VII, and factor VIII) significantly decreased in all groups [R].
In a study (DB-RCT) of 12 healthy adult males, a single dose of nattokinase degraded fibrin and decreased levels of coagulation factors, which are involved in blood clotting. Its effect lasted for a long time (over 8 hours) compared to other enzymes (tissue plasminogen activator, urokinase) [R].
In rats, its clot-dissolving activity was stronger than that of plasmin or elastase [R].
In rats with thrombosis, nattokinase decreased blood clots better than the saltwater solution. In addition, a high-dose of nattokinase was as effective in reducing blood clots as a known anti-clotting agent (vermis kinase) [R].
- Directly reduces fibrin clots 6 times more efficiently than plasmin
- Increases activity of anti-clotting enzymes (urokinase, t-PA)
- Reduces pro-clotting enzymes (PAI-1)
3) Nattokinase May Improve Blood Flow
Nattokinase improves blood flow by inhibiting blood cell clumping (platelet aggregation) and thrombus formation.
In rats, a high dose of nattokinase fully inhibited thrombus formation. This was similar to the effects of aspirin, a well-known blood thinner. Nevertheless, the lack of adverse effects associated with its consumption suggests that it could be an effective treatment for improving blood flow [R].
Blood clots were experimentally induced in dogs. Oral consumption of nattokinase dissolved the blood clots and restored normal blood flow in only 5 hours [R].
4) Nattokinase May Reduce Cholesterol
A study comparing nattokinase with statins (cholesterol-lowering drugs) randomly divided 82 patients into one of those treatments for 26 weeks. Both treatments reduced total cholesterol, LDL (the “bad” cholesterol), and triglycerides. However, only nattokinase consumption increased HDL (the “good” cholesterol) [R].
Other studies do not report a significant reduction in cholesterol levels or only showed a decrease in triglycerides levels. Hence, further studies are required to examine its effect on cholesterol levels. [R, R].
5) Nattokinase May Prevent Artery Hardening
Daily nattokinase supplementation was remarkably better at reducing plaque size (36.6% plaque reduction) that causes hardening of the arteries (atherosclerosis) compared to statin treatment (11.5% plaque reduction) in 82 patients. The mechanisms by which it reduces cholesterol levels and decreases plaque size that results in the prevention of artery hardening may be different from each other [R].
6) Nattokinase May Decrease Risk of Stroke
High von Willebrand Factor (vWF, a mediator released by damaged blood vessels that increases the risk of forming clots) levels are associated with the risk of stroke [R].
In a study (DB-RCT) of 79 hypertensive patients, vWF was reduced by 15% in the group who took nattokinase, compared to the placebo group that had no consistent change throughout the 8 weeks. However, vWF levels didn’t decrease in males who consumed the supplement. This suggests a gender-specific effect of nattokinase in reducing vWF levels [R].
7) Nattokinase May Treat Alzheimer’s Disease
In rats, nattokinase helped control factors that characterize Alzheimer’s disease [R].
Certain factors that are high in Alzheimer’s decreased with oral nattokinase consumption (acetylcholinesterase, TGF-β, Fas, and IL-6). Meanwhile, others that are usually low, increased with nattokinase treatment (BDNF and IGF-1) compared to untreated rats with Alzheimer’s disease characteristics. Thus, nattokinase may be a potential therapy for the treatment of Alzheimer’s [R].
8) Nattokinase May Treat Celiac Disease
Side Effects, Adverse Effects, and Dangers
Nattokinase is generally safe to consume since no side effects have been reported. This is based on a lack of reported side effects from human clinical trials and the fact that it has been a part of the Japanese diet for thousands of years [R, R, R].
Further human studies are needed to fully establish a safety profile.
Limitations and Caveats
Many benefits of nattokinase were studied in cells or animals. Even though the findings were significant, these benefits may or may not apply to humans. For that reason, more studies with humans are needed.
Nattokinase binds to heparin, a glycosaminoglycan used as an anticoagulant drug. Depending on the length of the heparin chain, nattokinase can interfere with heparin’s functions. It can also bind to other glycosaminoglycans [R].
Since nattokinase may cause blood thinning, it should not be paired with other blood thinning agents such as aspirin or warfarin. This can increase the risk of brain hemorrhage in patients who have small vessel disease [R].
There is also a risk of clotting mechanical heart valves if nattokinase is substituted for warfarin [R].
Nattokinase in Combination with Other Supplements
A combination of nattokinase and red yeast rice is more effective at reducing cholesterol than nattokinase alone.
In a clinical trial (DB-RCT), 47 subjects with high cholesterol levels (hyperlipidemia) received either nattokinase only, nattokinase and red yeast rice extract, or placebo for 6 months. Treatment with nattokinase only started to decrease blood cholesterol and triglyceride levels in the last month of the study. However, the combined therapy (nattokinase and red yeast rice) reduced levels of LDL, total cholesterol, and triglycerides, and increased HDL, from the first month onward [R].
It’s important to consider that red yeast rice itself may show these results, but that possibility was not explored in this study since it did not have a group of red yeast rice only.
Serine Protease from Streptomyces
A byproduct of the bacteria Streptomyces omiyaensis may increase the effectiveness of nattokinase.
In cells, a low concentration serine protease enzyme from Streptomyces omiyaensis enhanced the activity of nattokinase in reducing blood clots [R].
Nattokinase activity is measured in FU, the number of fibrinolytic units (FU).
Some consumers have been taking nattokinase for years to treat hardening of arteries, high blood pressure, or deep vein thrombosis. It worked for them without causing any side effects.
A user also found that it eliminated candida fungus from the intestines.
Other users have noticed excess bleeding (from the nose, or after a simple cut) and bruising (from slight traumas).